SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-183809
Filing Date
2023-07-07
Accepted
2023-07-07 16:18:56
Documents
2
Group Members
BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Document Format Files

Seq Description Document Type Size
1 SC 13D d526447dsc13d.htm SC 13D 91355
2 EX-99.1 d526447dex991.htm EX-99.1 6979
  Complete submission text file 0001193125-23-183809.txt   99858
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Subject) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88240 | Film No.: 231077000
SIC: 2834 Pharmaceutical Preparations

Mailing Address BINGER STRABE 173 INGELHEIM AM RHEIN 2M 55216
Business Address BINGER STRABE 173 INGELHEIM AM RHEIN 2M 55216 496132770
Boehringer AG (Filed by) CIK: 0001984047 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D